Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer
Oncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Jun 9, 2023
0
9